151 related articles for article (PubMed ID: 9617767)
1. Mutational analysis of discontinuous epitopes of foot-and-mouth disease virus using an unprocessed capsid protomer precursor.
Mateu MG; Escarmís C; Domingo E
Virus Res; 1998 Jan; 53(1):27-37. PubMed ID: 9617767
[TBL] [Abstract][Full Text] [Related]
2. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.
Sáiz JC; Cairó J; Medina M; Zuidema D; Abrams C; Belsham GJ; Domingo E; Vlak JM
J Virol; 1994 Jul; 68(7):4557-64. PubMed ID: 7515974
[TBL] [Abstract][Full Text] [Related]
3. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
Chinsangaram J; Beard C; Mason PW; Zellner MK; Ward G; Grubman MJ
J Virol; 1998 May; 72(5):4454-7. PubMed ID: 9557740
[TBL] [Abstract][Full Text] [Related]
4. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
5. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
[TBL] [Abstract][Full Text] [Related]
6. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E
J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204
[TBL] [Abstract][Full Text] [Related]
7. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
10. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
11. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
14. The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions.
Rowlands D; Logan D; Abu-Ghazaleh R; Blakemore W; Curry S; Jackson T; King A; Lea S; Lewis R; Newman J
Arch Virol Suppl; 1994; 9():51-8. PubMed ID: 8032279
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.
Domingo E; Verdaguer N; Ochoa WF; Ruiz-Jarabo CM; Sevilla N; Baranowski E; Mateu MG; Fita I
Virus Res; 1999 Aug; 62(2):169-75. PubMed ID: 10507326
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.
Kitson JD; McCahon D; Belsham GJ
Virology; 1990 Nov; 179(1):26-34. PubMed ID: 1699353
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
18. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
19. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
Gene; 1986; 49(2):189-97. PubMed ID: 2436976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
